---
title: "AQST.US (AQST.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/AQST.US/news.md"
symbol: "AQST.US"
name: "AQST.US"
parent: "https://longbridge.com/en/quote/AQST.US.md"
datetime: "2026-05-20T02:35:09.692Z"
locales:
  - [en](https://longbridge.com/en/quote/AQST.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/AQST.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/AQST.US/news.md)
---

# AQST.US (AQST.US) — Related News

### [Aquestive Therapeutics (AQST) Receives a Buy from Oppenheimer](https://longbridge.com/en/news/286564550.md)
*2026-05-15T12:01:48.000Z*
> Oppenheimer analyst Andreas Argyrides has reiterated a Buy rating on Aquestive Therapeutics (AQST) with a price target o

### [Aquestive Therapeutics Q1 2026 Earnings Call: Complete Transcript](https://longbridge.com/en/news/286423215.md)
*2026-05-14T13:09:51.000Z*
> Aquestive Therapeutics (NASDAQ:AQST) reported Q1 2026 revenue of $14.4 million, a 66% increase year-over-year, driven by

### [12 Health Care Stocks Moving In Wednesday's After-Market Session](https://longbridge.com/en/news/286319214.md)
*2026-05-13T21:06:19.000Z*
> In Wednesday's after-market session, Staar Surgical (STAA) shares surged 15.3% to $33.9 following Q1 earnings, while Pre

### [Aquestive Secures New Oaktree Term Loan to Fund Anaphylm](https://longbridge.com/en/news/286317797.md)
*2026-05-13T21:01:38.000Z*
> Aquestive Therapeutics has secured a new five-year term loan facility of up to $150 million with Oaktree, including a $5

### [](https://longbridge.com/en/news/286315765.md)
*2026-05-13T20:40:12.000Z*
> Aquestive Therapeutics shares are trading higher after the company reported better-than-expected Q1 financial results.

### [Aquestive Therapeutic | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 14.45 M](https://longbridge.com/en/news/286309807.md)
*2026-05-13T20:10:19.000Z*
### [Aquestive Therapeutics Completes $150 Million Debt Refinancing with Oaktree | AQST Stock News](https://longbridge.com/en/news/286110447.md)
*2026-05-12T05:31:00.000Z*
> Aquestive Therapeutics has completed a $150 million debt refinancing with Oaktree Capital Management. The new facility w